Aeon
Connecting Sign in

Insider trades appear within seconds, the rest within the hour.

Get alerts

← Feed

PBLSNasdaq

Parabilis Medicines, Inc.

Alert me on PBLS
5
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

PBLS stock chart by TradingView

After each filing

21
Jul 23 Buy RA CAPITAL MANAGEMENT, L.P. Insider
1 week
−1.6%S&P +0.5%
1 month
+20.0%S&P +3.7%
3 months
−15.1%S&P +5.0%
6 months
Result in50 trading days
Jul 23 Buy RA Capital Healthcare Fund LP Insider
1 week
−1.6%S&P +0.5%
1 month
+20.0%S&P +3.7%
3 months
−15.1%S&P +5.0%
6 months
Result in50 trading days
Jul 23 Buy RA Capital Nexus Fund III, L.P. Insider
1 week
−1.6%S&P +0.5%
1 month
+20.0%S&P +3.7%
3 months
−15.1%S&P +5.0%
6 months
Result in50 trading days
Jul 23 Buy Kolchinsky Peter Insider
1 week
−1.6%S&P +0.5%
1 month
+20.0%S&P +3.7%
3 months
−15.1%S&P +5.0%
6 months
Result in50 trading days
Jul 23 Buy Shah Rajeev M. Insider
1 week
−1.6%S&P +0.5%
1 month
+20.0%S&P +3.7%
3 months
−15.1%S&P +5.0%
6 months
Result in50 trading days
Show all 21
Jun 29 Buy Levy Guy Insider
1 week
+4.0%S&P +0.9%
1 month
+8.9%S&P −1.6%
3 months
+11.6%S&P +3.6%
6 months
Result in33 trading days
Jun 29 Buy Soleus Private Equity Fund III, L.P. Insider
1 week
+4.0%S&P +0.9%
1 month
+8.9%S&P −1.6%
3 months
+11.6%S&P +3.6%
6 months
Result in33 trading days
Jun 29 Buy Soleus Private Equity GP III, LLC Insider
1 week
+4.0%S&P +0.9%
1 month
+8.9%S&P −1.6%
3 months
+11.6%S&P +3.6%
6 months
Result in33 trading days
Jun 29 Buy Soleus PE GP III, LLC Insider
1 week
+4.0%S&P +0.9%
1 month
+8.9%S&P −1.6%
3 months
+11.6%S&P +3.6%
6 months
Result in33 trading days
Jun 29 Buy Soleus Capital Management, L.P. Insider
1 week
+4.0%S&P +0.9%
1 month
+8.9%S&P −1.6%
3 months
+11.6%S&P +3.6%
6 months
Result in33 trading days
Jun 29 Buy Soleus GP, LLC Insider
1 week
+4.0%S&P +0.9%
1 month
+8.9%S&P −1.6%
3 months
+11.6%S&P +3.6%
6 months
Result in33 trading days
Jun 29 Buy Soleus Capital Master Fund, L.P. Insider
1 week
+4.0%S&P +0.9%
1 month
+8.9%S&P −1.6%
3 months
+11.6%S&P +3.6%
6 months
Result in33 trading days
Jun 29 Buy Soleus Capital, LLC Insider
1 week
+4.0%S&P +0.9%
1 month
+8.9%S&P −1.6%
3 months
+11.6%S&P +3.6%
6 months
Result in33 trading days
Jun 29 Buy Soleus Capital Group, LLC Insider
1 week
+4.0%S&P +0.9%
1 month
+8.9%S&P −1.6%
3 months
+11.6%S&P +3.6%
6 months
Result in33 trading days
Jun 17 Buy SEBULSKY ALAN Insider
1 week
+1.3%S&P −0.6%
1 month
+4.9%S&P +0.4%
3 months
+57.0%S&P +3.2%
6 months
Result in26 trading days
Jun 16 Buy RA CAPITAL MANAGEMENT, L.P. Insider
1 week
+2.7%S&P −2.0%
1 month
+11.1%S&P −0.7%
3 months
+38.7%S&P +0.8%
6 months
Result in25 trading days
Jun 16 Buy RA Capital Healthcare Fund LP Insider
1 week
+2.7%S&P −2.0%
1 month
+11.1%S&P −0.7%
3 months
+38.7%S&P +0.8%
6 months
Result in25 trading days
Jun 16 Buy RA Capital Nexus Fund III, L.P. Insider
1 week
+2.7%S&P −2.0%
1 month
+11.1%S&P −0.7%
3 months
+38.7%S&P +0.8%
6 months
Result in25 trading days
Jun 16 Buy Kolchinsky Peter Insider
1 week
+2.7%S&P −2.0%
1 month
+11.1%S&P −0.7%
3 months
+38.7%S&P +0.8%
6 months
Result in25 trading days
Jun 16 Buy Shah Rajeev M. Insider
1 week
+2.7%S&P −2.0%
1 month
+11.1%S&P −0.7%
3 months
+38.7%S&P +0.8%
6 months
Result in25 trading days
Jun 16 Buy SEBULSKY ALAN Insider
1 week
+2.7%S&P −2.0%
1 month
+11.1%S&P −0.7%
3 months
+38.7%S&P +0.8%
6 months
Result in25 trading days

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for PBLS

20 held · newest 520 held · newest 2
Loading the filings.
See all 20 filings for PBLS

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
No lobbying reports on file.